Skip to content

Investigating the Effect of Silver spray on Pitting ulcer of scleroderma patients

Investigating the Effect of Silver spray on Pitting ulcer of scleroderma patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250810066799N1
Enrollment
10
Registered
2025-10-30
Start date
2025-12-22
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

scleroderma. Systemic sclerosis [scleroderma]

Interventions

Intervention 1: Intervention group: It involved one hand of the patient, which will be treated with Silvosept silver spray (Chitotic company) at a concentration of 40 ppm, applied twice daily for 3 mo

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to No maximum

Inclusion criteria

Inclusion criteria: Definite diagnosis of systemic sclerosis (scleroderma) confirmed by a specialist Presence of pitting ulcers on both hands No history of allergy or hypersensitivity to silver spray Having written informed consent to participate in the study

Exclusion criteria

Exclusion criteria: Whitout history of sympathectomy Development of allergic reaction or irritation following the use of silver spray Occurrence of necrotic tissue formation accompanied by discharge Death of the participant due to any cause before completion of the follow-up period Undergoing surgical intervention during the study period

Design outcomes

Primary

MeasureTime frame
The number of pitting ulcers on both hands of the patients. Timepoint: The number of pitting ulcers on both hands of the patients at the beginning of the study (before the intervention) and three months after the intervention. Method of measurement: The number of pitting (pinpoint) scars in scleroderma is recorded through a careful clinical examination of the hands and fingers and by counting the clearly visible lesions.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarzieh Mahdavi

Shahid Beheshti University of Medical Sciences

M.mahdavi70@gmail.com+98 21 2245 3538

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026